Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable NSCLC: A Case Exploration of New Standards and Emerging Approaches
See the latest #NSCLC live event from @PeerView @jdoningtonmd @DoctorJSpicer #AATS2024 #MedEd
See the latest #NSCLC live event from @PeerView @jdoningtonmd @DoctorJSpicer #AATS2024 #MedEd
ATLANTA — IVUS-guided angioplasty was superior to an angiography-guided approach for improving immediate procedural outcomes and 12-month patency in patients with symptomatic femoropopliteal artery disease,…
JCRP was the first, and remains the only, professional journal dedicated to improving multidisciplinary clinical practice and expanding research evidence specific to both cardiovascular and…
Research Highlights: When adults became angry after remembering past experiences, the function of cells lining the blood vessels was negatively impaired, which may restrict blood…
A-A is a coalition of charities, patient groups, patients, carers, medical groups and allied professionals. A-A provides support, information, education, and awareness to all those…
ATLANTA — For patients with nonobstructive hypertrophic cardiomyopathy, ninerafaxstat, a novel cardiac mitotrope, safely improved HF symptoms during a 12-week period vs. placebo, a speaker…
The official ESC website: Register here for the next Heart Failure congress and take advantage of the best rates by registering early.
This analysis shows that diabetic patients undergoing revascularization face substantially higher 5-year rates of all-cause mortality, myocardial infarction, repeat revascularizations, and stroke compared to non-diabetic…
Please note: DO NOT register for the Global Evidence Summit before you receive notification of the result of your stipend application.
Correspondence to: Jay Giri, MD, MPH, Perelman Center for Advanced Medicine, 3400 Civic Center Blvd, South Tower 11-105, Philadelphia, PA 19104. Email Cardiovascular Medicine Division,…